December 18, 2018
Merck to acquire 'agtech' company
Merck [NYSE:MRK], known as MSD outside the United States and Canada, and Antelliq Group announced last Friday that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC Partners.
Antelliq is a leader in digital animal identification, traceability and monitoring solutions, the "fastest growing" part of the animal health industry.
Antelliq will be a wholly-owned and separately-operated subsidiary within the Merck Animal Health Division. Merck will make a cash payment of about 2.1 billion euros to acquire all outstanding shares of Antelliq and will assume Antelliq's debt of 1.15 billion euros, which it intends to repay shortly after the closing of the acquisition.
Antelliq's solutions help veterinarians, farmers and pet owners gather data to improve management, health and well-being of livestock and pets. The increasing use of digital technology in animal agriculture is driven by the growing demand for protein, food traceability and food safety. Identification and monitoring technologies will help optimise disease prediction and treatment and this acquisition will provide Merck Animal Health with a large, established customer base in both areas.
The closing of the transaction is subject to clearance by antitrust and competition law authorities and other customary closing conditions, and is expected to close in the second quarter of 2019.